Compounds > pefloxacin
Page last updated: 2024-08-23

pefloxacin and Alcoholic Cirrhosis

pefloxacin has been researched along with Alcoholic Cirrhosis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eugène, C; Wesenfelder, L1
Bruno, R; Frydman, A; Gaillot, J; Iliadis, A; Le Roux, Y; Montay, G; Rosier, P1
Gaillot, J; Montay, G1
Beauchant, M; Becq-Giraudon, B; Breux, JP; Grollier, G; Rouffineau, J; Silvain, C1
Beauchant, M; Becq-Giraudon, B; Bouquet, S; Breux, JP; Cardey, J; Fourtillan, JP; Silvain, C1
Cunci, R; Danan, G; Erlinger, S; Montay, G1

Reviews

1 review(s) available for pefloxacin and Alcoholic Cirrhosis

ArticleYear
Pharmacokinetics of fluoroquinolones in hepatic failure.
    The Journal of antimicrobial chemotherapy, 1990, Volume: 26 Suppl B

    Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Female; Half-Life; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Metabolic Clearance Rate; Middle Aged; Ofloxacin; Pefloxacin

1990

Other Studies

5 other study(ies) available for pefloxacin and Alcoholic Cirrhosis

ArticleYear
[Peritoneal tuberculosis masked by fluoroquinolones in a patient with liver cirrhosis].
    Gastroenterologie clinique et biologique, 1993, Volume: 17, Issue:10

    Topics: Anti-Bacterial Agents; Ascites; Drug Therapy, Combination; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Norfloxacin; Pefloxacin; Peritonitis, Tuberculous

1993
Evaluation of Bayesian estimation to discriminate subpopulations of patients with altered pharmacokinetics using fragmentary data: a pilot study with pefloxacin.
    European journal of drug metabolism and pharmacokinetics, 1991, Volume: Spec No 3

    Topics: Adult; Bayes Theorem; Female; Half-Life; Humans; Kidney Diseases; Liver Cirrhosis, Alcoholic; Liver Diseases; Male; Pefloxacin; Pilot Projects; Regression Analysis

1991
[Can septicemia and ascitic fluid infections in cirrhotic patients be treated by the oral route alone?].
    Gastroenterologie clinique et biologique, 1989, Volume: 13, Issue:4

    Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Ascitic Fluid; Bacterial Infections; Drug Therapy, Combination; Female; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Pefloxacin; Prospective Studies; Sepsis; Time Factors

1989
Oral pharmacokinetics and ascitic fluid penetration of pefloxacin in cirrhosis.
    European journal of clinical pharmacology, 1987, Volume: 33, Issue:5

    Topics: Adult; Aged; Anti-Infective Agents; Ascitic Fluid; Diffusion; Female; Humans; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Norfloxacin; Pefloxacin

1987
Pefloxacin kinetics in cirrhosis.
    Clinical pharmacology and therapeutics, 1985, Volume: 38, Issue:4

    Topics: Adult; Aged; Biotransformation; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Infusions, Parenteral; Kinetics; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Norfloxacin; Pefloxacin

1985